Challenges and considerations in allogeneic cell therapy manufacturing
Discover the promise of unconventional cell types in allogenic cell therapy, the hurdles in manufacturing, and smart ways to overcome them.
Cell therapy is broadly categorized into autologous and allogeneic, depending on the source of cells used. Allogeneic cell therapies rely on donor cells, bringing unique manufacturing challenges.
In this infographic, you will learn more about:
- The fundamental differences between autologous and allogeneic cell therapy
- The use of unconventional cell types such as fibroblasts, epithelial cells, and keratinocytes for allogeneic applications
- Current challenges in allogeneic cell therapy manufacturing
- Approaches to overcome key barriers in allogeneic cell therapy
Download the infographic to better understand the complexities and innovations shaping allogeneic cell therapy.